var data={"title":"Etiology and clinical manifestations of renal tubular acidosis in infants and children","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Etiology and clinical manifestations of renal tubular acidosis in infants and children</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/contributors\" class=\"contributor contributor_credentials\">Tej K Mattoo, MD, DCH, FRCP</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/contributors\" class=\"contributor contributor_credentials\">F Bruder Stapleton, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/contributors\" class=\"contributor contributor_credentials\">Melanie S Kim, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jun 02, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In children, renal tubular acidosis (RTA) is due to either an inherited or acquired defect that affects the kidney's ability to absorb filtered bicarbonate, or excrete ammonia or titratable acid. RTA is characterized by a normal anion gap (hyperchloremic) metabolic acidosis caused by the net retention of hydrogen or loss of bicarbonate.</p><p>There are four subgroups of RTA (<a href=\"image.htm?imageKey=NEPH%2F58428\" class=\"graphic graphic_table graphicRef58428 \">table 1</a>):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Distal (type 1) RTA</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Proximal (type 2) RTA</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mixed (type 3) RTA</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypoaldosteronism (type 4 RTA)</p><p/><p>The most common pediatric forms of RTA are types 1 and 2.</p><p>The etiology and clinical manifestations of the different forms of RTA in infants and children will be reviewed here.</p><p>Other topics review the following aspects of RTA:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Diagnosis (see <a href=\"topic.htm?path=etiology-and-diagnosis-of-distal-type-1-and-proximal-type-2-renal-tubular-acidosis\" class=\"medical medical_review\">&quot;Etiology and diagnosis of distal (type 1) and proximal (type 2) renal tubular acidosis&quot;</a> and <a href=\"topic.htm?path=causes-and-evaluation-of-hyperkalemia-in-adults\" class=\"medical medical_review\">&quot;Causes and evaluation of hyperkalemia in adults&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pathophysiology (see <a href=\"topic.htm?path=overview-and-pathophysiology-of-renal-tubular-acidosis-and-the-effect-on-potassium-balance\" class=\"medical medical_review\">&quot;Overview and pathophysiology of renal tubular acidosis and the effect on potassium balance&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Treatment (see <a href=\"topic.htm?path=treatment-of-distal-type-1-and-proximal-type-2-renal-tubular-acidosis\" class=\"medical medical_review\">&quot;Treatment of distal (type 1) and proximal (type 2) renal tubular acidosis&quot;</a> and <a href=\"topic.htm?path=etiology-diagnosis-and-treatment-of-hypoaldosteronism-type-4-rta\" class=\"medical medical_review\">&quot;Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">DISTAL (TYPE 1) RTA</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Type 1 (distal) RTA is due to impaired distal acid secretion that results in an inability to excrete the daily acid load. In the absence of alkali therapy, progressive hydrogen ion retention leads to a fall in plasma bicarbonate concentration that is accompanied by an abnormally high urine pH (greater than 5.5) (<a href=\"image.htm?imageKey=NEPH%2F58428\" class=\"graphic graphic_table graphicRef58428 \">table 1</a>).</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Etiology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The etiology of distal RTA in children can be divided into genetic and acquired disorders (<a href=\"image.htm?imageKey=NEPH%2F56437\" class=\"graphic graphic_table graphicRef56437 \">table 2</a>).</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h3\">Genetic causes</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Genetic primary causes of distal RTA include mutations of genes that encode the chloride-bicarbonate exchanger (AE1) or subunits of the H-ATPase pump (<a href=\"image.htm?imageKey=PEDS%2F59008\" class=\"graphic graphic_table graphicRef59008 \">table 3</a>) [<a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/1,2\" class=\"abstract_t\">1,2</a>]. (See <a href=\"topic.htm?path=overview-and-pathophysiology-of-renal-tubular-acidosis-and-the-effect-on-potassium-balance\" class=\"medical medical_review\">&quot;Overview and pathophysiology of renal tubular acidosis and the effect on potassium balance&quot;</a>.) </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Dominant distal RTA &mdash; Mutations of the <em>SLC4A1</em> gene, located on chromosome 17q21-q22, which encodes the chloride-bicarbonate exchanger (AE1 or band 3), have been described in several families with autosomal dominant distal RTA [<a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/3-6\" class=\"abstract_t\">3-6</a>]. Patients with dominant distal RTA generally have milder acidosis than those with recessive disease and present later in life, often in adolescence or adulthood [<a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/7\" class=\"abstract_t\">7</a>]. Untreated patients have metabolic acidosis that is associated with hypercalciuria, nephrolithiasis or nephrocalcinosis, osteomalacia, and erythrocytosis. Mutations of the <em>SLC4A1</em> gene also are reported in some patients with hereditary spherocytosis and Southeast Asian ovalocytosis, both of which can be associated with RTA. (See <a href=\"topic.htm?path=hereditary-spherocytosis\" class=\"medical medical_review\">&quot;Hereditary spherocytosis&quot;</a> and <a href=\"topic.htm?path=hereditary-elliptocytosis-and-related-disorders#H9\" class=\"medical medical_review\">&quot;Hereditary elliptocytosis and related disorders&quot;, section on 'Southeast Asian ovalocytosis (SAO)'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Recessive distal RTA with deafness &mdash; Patients with mutations in the gene <em>ATP6V1B1</em>, which encodes the B1 subunit of H-ATPase, have distal RTA and sensorineural deafness [<a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/8,9\" class=\"abstract_t\">8,9</a>]. This gene is expressed in the intercalated cells of the distal renal tubule, cochlea, and male genital tract, and is located on chromosome 2p13 [<a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/8-11\" class=\"abstract_t\">8-11</a>]. Untreated patients develop severe metabolic acidosis with poor growth, rickets, and nephrocalcinosis during infancy and early childhood. Patients also may develop progressive bilateral sensorineural hearing loss (SNHL) that typically begins in infancy [<a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/12\" class=\"abstract_t\">12</a>]. Treatment of acidosis prevents poor growth, rickets, and nephrocalcinosis but does not improve or prevent ongoing hearing loss.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Recessive distal RTA without deafness:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Patients with mutations in the gene <em>ATP6V0A4</em>, located on chromosome 7q33-q34, which encodes the a4 subunit of H-ATPase, develop distal RTA without early hearing loss [<a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/13\" class=\"abstract_t\">13</a>]. The severity of metabolic acidosis and its associated findings of failure to thrive, rickets, and nephrocalcinosis are similar to that seen in patients with mutations that affect the B1 subunit. This gene product is also expressed in the inner ear, although most children with <em>ATP6V0A4</em> gene mutations have normal hearing based upon audiometric screening, there are cases with sensorineural hearing loss (SNHL) [<a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/2,14\" class=\"abstract_t\">2,14</a>].</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>In a report from Southeast Asia, a family with recessively transmitted distal RTA was associated with homozygosity for three mutations in <em>SLC4AE1 </em>[<a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/15\" class=\"abstract_t\">15</a>].</p><p/><p>Genetic disorders that cause secondary distal RTA include Ehlers-Danlos syndrome and sickle cell anemia. (See <a href=\"topic.htm?path=renal-manifestations-of-sickle-cell-disease#H10\" class=\"medical medical_review\">&quot;Renal manifestations of sickle cell disease&quot;, section on 'Renal tubular acidosis'</a>.)</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h3\">Acquired causes</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The acquired causes of distal RTA in children include the following:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Medications &mdash; The administration of amphotericin B can result in reversible distal RTA. However, the use of lipid formulations of amphotericin B avoids tubular damage and RTA. <a href=\"topic.htm?path=lithium-pediatric-drug-information\" class=\"drug drug_pediatric\">Lithium</a> can cause an incomplete distal RTA with impairment of urine acidification but typically does not cause metabolic acidosis. (See <a href=\"topic.htm?path=amphotericin-b-nephrotoxicity#H8\" class=\"medical medical_review\">&quot;Amphotericin B nephrotoxicity&quot;, section on 'Electrolyte disorders'</a> and <a href=\"topic.htm?path=renal-toxicity-of-lithium#H4\" class=\"medical medical_review\">&quot;Renal toxicity of lithium&quot;, section on 'Renal tubular acidosis'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Autoimmune disorders &mdash; Although rare in children, reported autoimmune conditions associated with distal RTA include Sj&ouml;gren syndrome [<a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/16\" class=\"abstract_t\">16</a>] and systemic lupus erythematosus [<a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/17,18\" class=\"abstract_t\">17,18</a>]. (See <a href=\"topic.htm?path=renal-disease-in-sjogrens-syndrome#H3\" class=\"medical medical_review\">&quot;Renal disease in Sj&ouml;gren's syndrome&quot;, section on 'Distal renal tubular acidosis'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Obstructive uropathy &mdash; Distal RTA may be present in patients with obstructive uropathy due to diminished sodium reabsorption by the principal cells of the distal renal tubule. (See <a href=\"topic.htm?path=overview-and-pathophysiology-of-renal-tubular-acidosis-and-the-effect-on-potassium-balance\" class=\"medical medical_review\">&quot;Overview and pathophysiology of renal tubular acidosis and the effect on potassium balance&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Clinical manifestations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The clinical manifestations of distal RTA vary depending upon the underlying etiology. The recessive genetic forms present in infancy, the dominant form later in life, and acquired distal RTA may occur at any age based upon the timing of renal tubular injury. </p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h3\">Recessive form</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>As discussed previously, the recessive genetic form of RTA usually presents during infancy and generally is associated with severe clinical manifestations [<a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/2,19\" class=\"abstract_t\">2,19</a>]. These findings include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Severe hyperchloremic metabolic acidosis (serum bicarbonate levels may decrease below 10 <span class=\"nowrap\">mEq/L)</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Moderate to severe hypokalemia (serum potassium &le; 3.0 <span class=\"nowrap\">mEq/L)</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nephrocalcinosis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Vomiting</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Dehydration</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Poor growth</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Rickets</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Bilateral SNHL in some cases with mutations of the gene that encodes B1 subunit of the H-ATPase pump (see <a href=\"#H4\" class=\"local\">'Genetic causes'</a> above)</p><p/><p class=\"headingAnchor\" id=\"H8\"><span class=\"h3\">Dominant form</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In comparison with recessive distal RTA, dominant distal RTA is usually associated with milder disease, and presents later in life (often in adolescence and adulthood). The most common initial finding is renal stone or nephrocalcinosis. Patients typically have mild or no acidosis, mild to moderate hypokalemia, and less commonly, poor growth [<a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/2,3,19\" class=\"abstract_t\">2,3,19</a>]. Bone disease is a rare finding. </p><p>The clinical manifestations of dominant distal RTA were illustrated in a study of 18 patients from four families [<a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/3\" class=\"abstract_t\">3</a>]. Ten patients had mild acidosis with serum bicarbonate levels that ranged from 15 to 21 <span class=\"nowrap\">mEq/L</span>. The remaining eight patients had impaired urinary acidification, but were not acidotic (serum bicarbonate level &ge; 22 <span class=\"nowrap\">mEq/L)</span>. These patients were diagnosed with incomplete distal RTA. All patients with complete RTA had either renal stones or nephrocalcinosis. Only one patient had rickets; the rest of the cases had no evidence of bone disease. Twelve patients had normal serum potassium levels, five had <span class=\"nowrap\">mild/moderate</span> hypokalemia (serum potassium levels between 3.0 to 3.4 <span class=\"nowrap\">mEq/L),</span> and one patient had severe hypokalemia (serum potassium of 2.1 <span class=\"nowrap\">mEq/L)</span>. (See <a href=\"topic.htm?path=etiology-and-diagnosis-of-distal-type-1-and-proximal-type-2-renal-tubular-acidosis#H10\" class=\"medical medical_review\">&quot;Etiology and diagnosis of distal (type 1) and proximal (type 2) renal tubular acidosis&quot;, section on 'Incomplete distal RTA'</a>.)</p><p class=\"headingAnchor\" id=\"H1355765948\"><span class=\"h3\">Chronic kidney disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Chronic kidney disease (CKD), defined as a glomerular filtration rate of &lt;90 <span class=\"nowrap\">cc/min</span> per 1.73 m<sup>2</sup>, has been reported as a complication of hereditary distal RTA [<a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/2\" class=\"abstract_t\">2</a>]. CKD presents after the pubertal growth spurt and is thought to be due to the combination of nephrocalcinosis, persistent hypokalemia, and repeated episodes of hypovolemia that results in progressive tubulointerstitial injury.</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h1\">PROXIMAL (TYPE 2) RTA</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Proximal RTA is caused by a reduction in proximal bicarbonate reabsorptive capacity resulting in a fall in the plasma bicarbonate. (See <a href=\"topic.htm?path=overview-and-pathophysiology-of-renal-tubular-acidosis-and-the-effect-on-potassium-balance#H42786907\" class=\"medical medical_review\">&quot;Overview and pathophysiology of renal tubular acidosis and the effect on potassium balance&quot;, section on 'Proximal (type 2) RTA'</a>.)</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">Etiology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Proximal RTA may present either as an isolated tubular defect or as a component of a generalized proximal tubular disorder called the Fanconi syndrome (<a href=\"image.htm?imageKey=NEPH%2F68165\" class=\"graphic graphic_table graphicRef68165 \">table 4</a>).</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h3\">Isolated proximal RTA</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In children, isolated proximal RTA is rare. It is usually due to an inherited (<a href=\"image.htm?imageKey=PEDS%2F59008\" class=\"graphic graphic_table graphicRef59008 \">table 3</a>) or transient disorder.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Transient or sporadic proximal RTA &ndash; Infants with transient or sporadic proximal RTA have a decreased capacity to bind bicarbonate without any identifiable cause or evidence of renal abnormality. These infants who are beyond the newborn period are believed to have extended functional immaturity of the proximal sodium-hydrogen exchanger (or antiporter), resulting in an age-based decrease in bicarbonate reabsorption capacity. This reduced capacity, which is the same as that of a normal neonate, results in a persistently low serum bicarbonate level [<a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/20\" class=\"abstract_t\">20</a>]. Patients usually present within the first year of life with symptoms of tachypnea, growth failure, recurrent vomiting, and feeding difficulties [<a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/21,22\" class=\"abstract_t\">21,22</a>]. Bone disease, hypokalemia, and urinary concentration defects are uncommon, and hypercalciuria, nephrocalcinosis, and urolithiasis do not occur. Resolution of symptoms and a rapid increase in growth are seen with alkali therapy, which can be discontinued after several years without recurrence of RTA and its symptoms.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Autosomal recessive proximal RTA &ndash; Mutations in the gene <em>SLC4A4</em>, which encodes the <a href=\"topic.htm?path=sodium-bicarbonate-pediatric-drug-information\" class=\"drug drug_pediatric\">sodium bicarbonate</a> cotransporter (NBC), are associated with isolated proximal RTA [<a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/23-25\" class=\"abstract_t\">23-25</a>]. This rare disorder with reported cases from Europe and Japan presents with severe hypokalemic, hyperchloremic, metabolic acidosis, growth retardation, and ocular abnormalities including glaucoma, cataracts, and band keratopathy. Ocular findings may progress with age [<a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/24,26\" class=\"abstract_t\">24,26</a>]. Additional features include enamel defects of the permanent teeth, impaired psychomotor and cognitive function, and opacification of the basal ganglia [<a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/27,28\" class=\"abstract_t\">27,28</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Autosomal dominant proximal RTA &ndash; Case reports have described a rare autosomal dominant inheritance pattern of proximal RTA in two families with several affected members [<a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/29,30\" class=\"abstract_t\">29,30</a>]. In both these families, clinical manifestations were limited to short stature and metabolic acidosis. There was no evidence of bone disease or hypercalciuria. No mutation was found in any of the nine tested candidate genes studied in the Israeli pedigree [<a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/30\" class=\"abstract_t\">30</a>].</p><p/><p>Studies using a knockout mouse model identified the gene <em>SLC9A3</em> as a candidate gene for dominant proximal RTA [<a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/31\" class=\"abstract_t\">31</a>]. It encodes one of the five plasma membrane sodium-hydrogen exchangers.</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h3\">Fanconi syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Generalized proximal tubular dysfunction, referred to as Fanconi syndrome, is characterized by hypophosphatemia due to phosphaturia, renal glucosuria (glucosuria with a normal plasma glucose concentration), aminoaciduria, tubular proteinuria, and proximal RTA.</p><p>The etiology of Fanconi syndrome includes inherited diseases or acquired causes:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Genetic conditions associated with Fanconi syndrome include the following:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Dent disease (see <a href=\"topic.htm?path=dent-disease-x-linked-recessive-nephrolithiasis#H7\" class=\"medical medical_review\">&quot;Dent disease (X-linked recessive nephrolithiasis)&quot;, section on 'Proximal tubular reabsorptive failure and proteinuria'</a>)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Cystinosis (see <a href=\"topic.htm?path=cystinosis#H8\" class=\"medical medical_review\">&quot;Cystinosis&quot;, section on 'Renal findings'</a>)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Tyrosinemia type 1 (see <a href=\"topic.htm?path=disorders-of-tyrosine-metabolism#H4\" class=\"medical medical_review\">&quot;Disorders of tyrosine metabolism&quot;, section on 'Hereditary tyrosinemia type 1'</a>)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Galactosemia (see <a href=\"topic.htm?path=galactosemia-clinical-features-and-diagnosis#H6\" class=\"medical medical_review\">&quot;Galactosemia: Clinical features and diagnosis&quot;, section on 'Clinical features'</a>)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Wilson disease (see <a href=\"topic.htm?path=wilson-disease-clinical-manifestations-diagnosis-and-natural-history#H69500456\" class=\"medical medical_review\">&quot;Wilson disease: Clinical manifestations, diagnosis, and natural history&quot;, section on 'Other manifestations'</a>)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Lowe oculocerebrorenal syndrome (<a href=\"http://www.omim.org/entry/309000&amp;token=G+kOOgscg7PQzd0gXq5S96hrEODiSszrPICEXHQdlxff7xtAHI/wpiyIGm/iqT3B&amp;TOPIC_ID=6121\" target=\"_blank\" class=\"external\">MIM #309000</a>), also referred to as Lowe syndrome (see <a href=\"topic.htm?path=dent-disease-x-linked-recessive-nephrolithiasis#H4\" class=\"medical medical_review\">&quot;Dent disease (X-linked recessive nephrolithiasis)&quot;, section on 'OCRL1 gene and the Lowe oculocerebrorenal syndrome'</a>)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Hereditary fructose intolerance</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Mitochondrial myopathies (see <a href=\"topic.htm?path=renal-involvement-in-the-mitochondrial-cytopathies#H7\" class=\"medical medical_review\">&quot;Renal involvement in the mitochondrial cytopathies&quot;, section on 'Tubular disease'</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Acquired causes of Fanconi syndrome include:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Drugs &ndash; Medication associated with Fanconi syndrome include aminoglycosides, <a href=\"topic.htm?path=cisplatin-pediatric-drug-information\" class=\"drug drug_pediatric\">cisplatin</a>, <a href=\"topic.htm?path=ifosfamide-pediatric-drug-information\" class=\"drug drug_pediatric\">ifosfamide</a>, valproic acid, and <a href=\"topic.htm?path=deferasirox-pediatric-drug-information\" class=\"drug drug_pediatric\">deferasirox</a> [<a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/32-34\" class=\"abstract_t\">32-34</a>]. (See <a href=\"topic.htm?path=manifestations-of-and-risk-factors-for-aminoglycoside-nephrotoxicity#H5\" class=\"medical medical_review\">&quot;Manifestations of and risk factors for aminoglycoside nephrotoxicity&quot;, section on 'Electrolyte abnormalities'</a> and <a href=\"topic.htm?path=ifosfamide-nephrotoxicity#H3\" class=\"medical medical_review\">&quot;Ifosfamide nephrotoxicity&quot;, section on 'Clinical manifestations'</a> and <a href=\"topic.htm?path=cisplatin-nephrotoxicity#H11\" class=\"medical medical_review\">&quot;Cisplatin nephrotoxicity&quot;, section on 'Fanconi-like syndrome'</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Heavy metals &ndash; Heavy metals associated with Fanconi syndrome include lead, mercury, and cadmium. (See <a href=\"topic.htm?path=lead-nephropathy-and-lead-related-nephrotoxicity#H6\" class=\"medical medical_review\">&quot;Lead nephropathy and lead-related nephrotoxicity&quot;, section on 'Clinical manifestations'</a> and <a href=\"topic.htm?path=epidemiology-and-toxicity-of-cadmium#H7\" class=\"medical medical_review\">&quot;Epidemiology and toxicity of cadmium&quot;, section on 'Kidney disease'</a> and <a href=\"topic.htm?path=mercury-toxicity#H3541308736\" class=\"medical medical_review\">&quot;Mercury toxicity&quot;, section on 'Tubular dysfunction'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H13\"><span class=\"h2\">Clinical features</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The clinical manifestations associated with proximal RTA vary depending upon whether the tubular acidosis is an isolated finding or is a part of the Fanconi syndrome.</p><p>The clinical manifestations of the rare causes of isolated proximal RTA are discussed previously. (See <a href=\"#H11\" class=\"local\">'Isolated proximal RTA'</a> above.)</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h3\">Clinical findings of Fanconi syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In children with Fanconi syndrome, the age of presentation varies with the underlying etiology.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Several genetic causes of Fanconi appear during infancy, including Lowe oculocerebrorenal syndrome, the infantile form of cystinosis, and Dent disease. (See <a href=\"topic.htm?path=dent-disease-x-linked-recessive-nephrolithiasis#H7\" class=\"medical medical_review\">&quot;Dent disease (X-linked recessive nephrolithiasis)&quot;, section on 'Proximal tubular reabsorptive failure and proteinuria'</a> and <a href=\"topic.htm?path=dent-disease-x-linked-recessive-nephrolithiasis#H4\" class=\"medical medical_review\">&quot;Dent disease (X-linked recessive nephrolithiasis)&quot;, section on 'OCRL1 gene and the Lowe oculocerebrorenal syndrome'</a> and <a href=\"topic.htm?path=cystinosis#H4\" class=\"medical medical_review\">&quot;Cystinosis&quot;, section on 'Infantile form'</a>.)</p><p/><p>Other genetic conditions, such as Wilson disease, late-onset forms of cystinosis, and galactosemia present with Fanconi syndrome later in life as accumulation of toxic material (eg, copper in Wilson disease) over time results in progressive proximal renal tubular damage. (See <a href=\"topic.htm?path=galactosemia-clinical-features-and-diagnosis#H6\" class=\"medical medical_review\">&quot;Galactosemia: Clinical features and diagnosis&quot;, section on 'Clinical features'</a> and <a href=\"topic.htm?path=cystinosis#H10\" class=\"medical medical_review\">&quot;Cystinosis&quot;, section on 'Late-onset (juvenile) cystinosis'</a> and <a href=\"topic.htm?path=wilson-disease-clinical-manifestations-diagnosis-and-natural-history#H69500456\" class=\"medical medical_review\">&quot;Wilson disease: Clinical manifestations, diagnosis, and natural history&quot;, section on 'Other manifestations'</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Acquired Fanconi may occur at any age depending upon the timing of exposure to noxious toxins and drugs, which injure the proximal tubule.</p><p/><p>In children, the most common clinical findings of Fanconi syndrome are growth failure, and episodes of hypovolemia due to polyuria caused by impaired concentrating ability. Poor growth may be due to hypophosphatemia, persistent acidosis, chronic hypokalemia, rickets, and volume depletion [<a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/35\" class=\"abstract_t\">35</a>]. Other findings may include bony abnormalities, including rickets and osteomalacia due to hypophosphatemia and low levels of calcitriol (1,25 dihydroxy vitamin D), and constipation and muscle weakness caused by significant hypokalemia (serum potassium less than 3 <span class=\"nowrap\">mEq/L)</span>. (See <a href=\"topic.htm?path=clinical-manifestations-and-treatment-of-hypokalemia-in-adults#H3819896\" class=\"medical medical_review\">&quot;Clinical manifestations and treatment of hypokalemia in adults&quot;, section on 'Severe muscle weakness or rhabdomyolysis'</a>.)</p><p>Laboratory evaluation demonstrates hyperchloremic metabolic acidosis, hypophosphatemia, moderate to severe hypokalemia (serum potassium levels less than 3 <span class=\"nowrap\">mEq/L),</span> and proteinuria.</p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h1\">MIXED (TYPE 3) RTA</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Type 3 RTA, also referred to as mixed RTA, is a rare autosomal recessive disorder that has features of both distal and proximal RTA. It is due to an inherited carbonic anhydrase (CA) 2 deficiency.</p><p>Because <em>CA2</em> is widely expressed, mutations of the <em>CA2</em> gene (located on chromosome 8q22) result in a syndrome with multiple clinical findings, including mixed RTA, osteopetrosis, cerebral calcification, and mental retardation [<a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/36-39\" class=\"abstract_t\">36-39</a>]. This constellation of findings is also referred to as Guibaud-Vainsel syndrome or marble brain disease. Other clinical features include bone fractures (due to increased bone fragility) and growth failure [<a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/40\" class=\"abstract_t\">40</a>]. Excessive facial bone growth leads to facial dysmorphism, and conductive hearing loss and blindness due to nerve compression. The majority of affected patients are of Arabic descent and live in North Africa and the Middle East.</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h1\">ALDOSTERONE DEFICIENCY OR RESISTANCE (TYPE 4 RTA)</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hypoaldosteronism is uncommon in children. It is due to either aldosterone deficiency or tubular resistance to the action of aldosterone (ie, mineralocorticoid deficiency). Because aldosterone is the major hormone that promotes potassium excretion, hypoaldosteronism is typically characterized by hyperkalemia and mild acidosis (serum bicarbonate above 17 <span class=\"nowrap\">mEq/L)</span>. Other clinical features in children with hypoaldosteronism may include failure to thrive and hyponatremia because of sodium loss.</p><p>Unlike adults, in whom the most common causes for a lack of response to aldosterone are kidney damage due to diabetic nephropathy or chronic interstitial nephritis, hypoaldosteronism in children is more likely to be due to drugs that impair aldosterone release or function (<a href=\"image.htm?imageKey=NEPH%2F82440\" class=\"graphic graphic_table graphicRef82440 \">table 5</a>). These include heparin, nonsteroidal antiinflammatory agents, angiotensin inhibitors, <a href=\"topic.htm?path=trimethoprim-pediatric-drug-information\" class=\"drug drug_pediatric\">trimethoprim</a>, calcineurin inhibitors (<a href=\"topic.htm?path=cyclosporine-ciclosporin-pediatric-drug-information\" class=\"drug drug_pediatric\">cyclosporine</a> and <a href=\"topic.htm?path=tacrolimus-pediatric-drug-information\" class=\"drug drug_pediatric\">tacrolimus</a>), and potassium sparing diuretics (eg, <a href=\"topic.htm?path=spironolactone-pediatric-drug-information\" class=\"drug drug_pediatric\">spironolactone</a>). In addition, human immunodeficiency virus (HIV) infection is also associated with hypoaldosteronism [<a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/41\" class=\"abstract_t\">41</a>]. (See <a href=\"topic.htm?path=etiology-diagnosis-and-treatment-of-hypoaldosteronism-type-4-rta#H2\" class=\"medical medical_review\">&quot;Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)&quot;, section on 'Etiology'</a>.)</p><p>In children, hypoaldosteronism due to inherited disorders include the following rare disorders, which are discussed in greater detail separately (see <a href=\"topic.htm?path=etiology-diagnosis-and-treatment-of-hypoaldosteronism-type-4-rta#H2\" class=\"medical medical_review\">&quot;Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)&quot;, section on 'Etiology'</a> and <a href=\"topic.htm?path=causes-and-clinical-manifestations-of-primary-adrenal-insufficiency-in-children#H10\" class=\"medical medical_review\">&quot;Causes and clinical manifestations of primary adrenal insufficiency in children&quot;, section on 'Disorders of steroidogenesis'</a>):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Congenital adrenal insufficiency</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Aldosterone synthase deficiency</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pseudohypoaldosteronism distal and 2 (also known as Gordon syndrome)</p><p/><p class=\"headingAnchor\" id=\"H17\"><span class=\"h1\">SUMMARY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Renal tubular acidosis (RTA) is due to either an inherited or acquired renal tubular defect that affects the kidney's ability to absorb filtered bicarbonate, or excrete ammonia or titratable acid. It is characterized by a normal anion gap (hyperchloremic) metabolic acidosis caused by the net retention of hydrogen or the net loss of bicarbonate.</p><p>There are four subgroups of RTA. The most common pediatric forms are distal (type 1) RTA and proximal (type 2) RTA.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Distal (type 1) RTA is due to impaired distal acid secretion that results in an inability to excrete the daily acid load. It is divided into genetic causes due to mutations of genes that encode the chloride-bicarbonate exchanger (AE1) or subunits of the H-ATPase pump, and acquired causes due to distal tubular injury from drugs, autoimmune disorders, or obstructive uropathy. (See <a href=\"#H3\" class=\"local\">'Etiology'</a> above.)</p><p/><p>Clinical manifestations of distal RTA are dependent upon the underlying etiology. Recessive autosomal distal RTA generally presents in infancy and is associated with more severe disease than the dominant form, which presents later in life. (See <a href=\"#H6\" class=\"local\">'Clinical manifestations'</a> above.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Proximal (type 2) RTA is caused by a reduction in proximal renal tubular bicarbonate reabsorptive capacity, resulting in a fall in the plasma bicarbonate. Its etiology is divided into disorders with isolated RTA and those with generalized proximal tubular dysfunction, referred to as Fanconi syndrome. (See <a href=\"#H10\" class=\"local\">'Etiology'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>In children, isolated proximal RTA is rare and is usually due to an inherited or transient disorder. Clinical features vary with the underlying etiology. (See <a href=\"#H11\" class=\"local\">'Isolated proximal RTA'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Fanconi syndrome is the most common cause of proximal RTA in children and is caused by inherited diseases (eg, Dent disease and cystinosis) and acquired disorders (eg, heavy metal toxicity and drugs). It is characterized by phosphaturia resulting in hypophosphatemia, renal glucosuria, aminoaciduria, tubular proteinuria, and proximal RTA. The age of clinical presentation depends upon the underlying etiology. Clinical findings include growth failure, hypovolemia, bony abnormalities (eg, rickets and osteomalacia), and constipation and muscle weakness due to hypokalemia. (See <a href=\"#H12\" class=\"local\">'Fanconi syndrome'</a> above and <a href=\"#H14\" class=\"local\">'Clinical findings of Fanconi syndrome'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mixed (type 3) RTA is a rare autosomal recessive disorder that has features of both types 1 and 2 RTA. It is due to an inherited carbonic anhydrase (CA) 2 deficiency. (See <a href=\"#H15\" class=\"local\">'Mixed (type 3) RTA'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Aldosterone deficiency or resistance (type 4 RTA) is due to either aldosterone deficiency or tubular resistance to the action of aldosterone. It is uncommon in children and is generally characterized by hyperkalemia and mild acidosis (serum bicarbonate above 17 <span class=\"nowrap\">mEq/L)</span>. In children, the most common cause of hypoaldosteronism is drugs (eg, heparin, nonsteroidal antiinflammatory agents, angiotensin inhibitors, <a href=\"topic.htm?path=trimethoprim-pediatric-drug-information\" class=\"drug drug_pediatric\">trimethoprim</a>, calcineurin inhibitors, and potassium sparing diuretics) that impair aldosterone release or function. Human immunodeficiency virus (HIV) may also be associated with hypoaldosteronism. (See <a href=\"#H16\" class=\"local\">'Aldosterone deficiency or resistance (type 4 RTA)'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/1\" class=\"nounderline abstract_t\">Besouw MTP, Bienias M, Walsh P, et al. Clinical and molecular aspects of distal renal tubular acidosis in children. Pediatr Nephrol 2017; 32:987.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/2\" class=\"nounderline abstract_t\">Palazzo V, Provenzano A, Becherucci F, et al. The genetic and clinical spectrum of a large cohort of patients with distal renal tubular acidosis. Kidney Int 2017; 91:1243.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/3\" class=\"nounderline abstract_t\">Bruce LJ, Cope DL, Jones GK, et al. Familial distal renal tubular acidosis is associated with mutations in the red cell anion exchanger (Band 3, AE1) gene. J Clin Invest 1997; 100:1693.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/4\" class=\"nounderline abstract_t\">Jarolim P, Shayakul C, Prabakaran D, et al. Autosomal dominant distal renal tubular acidosis is associated in three families with heterozygosity for the R589H mutation in the AE1 (band 3) Cl-/HCO3- exchanger. J Biol Chem 1998; 273:6380.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/5\" class=\"nounderline abstract_t\">Karet FE, Gainza FJ, Gy&ouml;ry AZ, et al. Mutations in the chloride-bicarbonate exchanger gene AE1 cause autosomal dominant but not autosomal recessive distal renal tubular acidosis. Proc Natl Acad Sci U S A 1998; 95:6337.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/6\" class=\"nounderline abstract_t\">Hu PY, Roth DE, Skaggs LA, et al. A splice junction mutation in intron 2 of the carbonic anhydrase II gene of osteopetrosis patients from Arabic countries. Hum Mutat 1992; 1:288.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/7\" class=\"nounderline abstract_t\">Agroyannis B, Koutsikos D, Tzanatos-Exarchou H, Yatzidis H. Erythrocytosis in type I renal tubular acidosis with nephrocalcinosis. Nephrol Dial Transplant 1992; 7:365.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/8\" class=\"nounderline abstract_t\">Royer P, Broyer M, Nordmann Y. [Enzymatic anomalies and human nephropathies]. Pathol Biol 1967; 15:803.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/9\" class=\"nounderline abstract_t\">Karet FE, Finberg KE, Nelson RD, et al. Mutations in the gene encoding B1 subunit of H+-ATPase cause renal tubular acidosis with sensorineural deafness. Nat Genet 1999; 21:84.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/10\" class=\"nounderline abstract_t\">Sterkers O, Saumon G, Tran Ba Huy P, et al. Electrochemical heterogeneity of the cochlear endolymph: effect of acetazolamide. Am J Physiol 1984; 246:F47.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/11\" class=\"nounderline abstract_t\">Herak-Kramberger CM, Breton S, Brown D, et al. Distribution of the vacuolar H+ atpase along the rat and human male reproductive tract. Biol Reprod 2001; 64:1699.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/12\" class=\"nounderline abstract_t\">Joshua B, Kaplan DM, Raveh E, et al. Audiometric and imaging characteristics of distal renal tubular acidosis and deafness. J Laryngol Otol 2008; 122:193.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/13\" class=\"nounderline abstract_t\">Karet FE, Finberg KE, Nayir A, et al. Localization of a gene for autosomal recessive distal renal tubular acidosis with normal hearing (rdRTA2) to 7q33-34. Am J Hum Genet 1999; 65:1656.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/14\" class=\"nounderline abstract_t\">Stover EH, Borthwick KJ, Bavalia C, et al. Novel ATP6V1B1 and ATP6V0A4 mutations in autosomal recessive distal renal tubular acidosis with new evidence for hearing loss. J Med Genet 2002; 39:796.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/15\" class=\"nounderline abstract_t\">Tanphaichitr VS, Sumboonnanonda A, Ideguchi H, et al. Novel AE1 mutations in recessive distal renal tubular acidosis. Loss-of-function is rescued by glycophorin A. J Clin Invest 1998; 102:2173.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/16\" class=\"nounderline abstract_t\">Pessler F, Emery H, Dai L, et al. The spectrum of renal tubular acidosis in paediatric Sj&ouml;gren syndrome. Rheumatology (Oxford) 2006; 45:85.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/17\" class=\"nounderline abstract_t\">Hataya H, Ikeda M, Ide Y, et al. Distal tubular dysfunction in lupus nephritis of childhood and adolescence. Pediatr Nephrol 1999; 13:846.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/18\" class=\"nounderline abstract_t\">Bagga A, Jain Y, Srivastava RN, Bhuyan UN. Renal tubular acidosis preceding systemic lupus erythematosus. Pediatr Nephrol 1993; 7:735.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/19\" class=\"nounderline abstract_t\">Batlle D, Ghanekar H, Jain S, Mitra A. Hereditary distal renal tubular acidosis: new understandings. Annu Rev Med 2001; 52:471.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/20\" class=\"nounderline abstract_t\">Rodr&iacute;guez-Soriano J. New insights into the pathogenesis of renal tubular acidosis--from functional to molecular studies. Pediatr Nephrol 2000; 14:1121.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/21\" class=\"nounderline abstract_t\">Nash MA, Torrado AD, Greifer I, et al. Renal tubular acidosis in infants and children. Clinical course, response to treatment, and prognosis. J Pediatr 1972; 80:738.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/22\" class=\"nounderline abstract_t\">Rodriguez Soriano J, Boichis H, Stark H, Edelmann CM Jr. Proximal renal tubular acidosis. A defect in bicarbonate reabsorption with normal urinary acidification. Pediatr Res 1967; 1:81.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/23\" class=\"nounderline abstract_t\">Donckerwolcke RA, van Stekelenburg GJ, Tiddens HA. A case of bicarbonate-losing renal tubular acidosis with defective carboanhydrase activity. Arch Dis Child 1970; 45:769.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/24\" class=\"nounderline abstract_t\">Igarashi T, Inatomi J, Sekine T, et al. Mutations in SLC4A4 cause permanent isolated proximal renal tubular acidosis with ocular abnormalities. Nat Genet 1999; 23:264.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/25\" class=\"nounderline abstract_t\">Jentsch TJ, Keller SK, Koch M, Wiederholt M. Evidence for coupled transport of bicarbonate and sodium in cultured bovine corneal endothelial cells. J Membr Biol 1984; 81:189.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/26\" class=\"nounderline abstract_t\">Igarashi T, Inatomi J, Sekine T, et al. Novel nonsense mutation in the Na+/HCO3- cotransporter gene (SLC4A4) in a patient with permanent isolated proximal renal tubular acidosis and bilateral glaucoma. J Am Soc Nephrol 2001; 12:713.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/27\" class=\"nounderline abstract_t\">Winsnes A, Monn E, Stokke O, Feyling T. Congenital persistent proximal type renal tubular acidosis in two brothers. Acta Paediatr Scand 1979; 68:861.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/28\" class=\"nounderline abstract_t\">Igarashi T, Ishii T, Watanabe K, et al. Persistent isolated proximal renal tubular acidosis--a systemic disease with a distinct clinical entity. Pediatr Nephrol 1994; 8:70.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/29\" class=\"nounderline abstract_t\">Brenes LG, Brenes JN, Hernandez MM. Familial proximal renal tubular acidosis. A distinct clinical entity. Am J Med 1977; 63:244.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/30\" class=\"nounderline abstract_t\">Katzir Z, Dinour D, Reznik-Wolf H, et al. Familial pure proximal renal tubular acidosis--a clinical and genetic study. Nephrol Dial Transplant 2008; 23:1211.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/31\" class=\"nounderline abstract_t\">Wang T, Yang CL, Abbiati T, et al. Mechanism of proximal tubule bicarbonate absorption in NHE3 null mice. Am J Physiol 1999; 277:F298.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/32\" class=\"nounderline abstract_t\">Knights MJ, Finlay E. The effects of sodium valproate on the renal function of children with epilepsy. Pediatr Nephrol 2014; 29:1131.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/33\" class=\"nounderline abstract_t\">Hall AM, Bass P, Unwin RJ. Drug-induced renal Fanconi syndrome. QJM 2014; 107:261.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/34\" class=\"nounderline abstract_t\">Chuang GT, Tsai IJ, Tsau YK, Lu MY. Transfusion-dependent thalassaemic patients with renal Fanconi syndrome due to deferasirox use. Nephrology (Carlton) 2015; 20:931.</a></li><li class=\"breakAll\">Foreman, JW. Fanconi syndrome and cystinosis. In: Pediatric Nephrology, 3rd ed, Holliday, MA, Barratt, TM, Avner, ED (Eds), Williams &amp; Wilkins, Philadelphia 1994. p.537.</li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/36\" class=\"nounderline abstract_t\">Tashian RE. Genetics of the mammalian carbonic anhydrases. Adv Genet 1992; 30:321.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/37\" class=\"nounderline abstract_t\">Sly WS, Hewett-Emmett D, Whyte MP, et al. Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc Natl Acad Sci U S A 1983; 80:2752.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/38\" class=\"nounderline abstract_t\">Whyte MP, Murphy WA, Fallon MD, et al. Osteopetrosis, renal tubular acidosis and basal ganglia calcification in three sisters. Am J Med 1980; 69:64.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/39\" class=\"nounderline abstract_t\">Roth DE, Venta PJ, Tashian RE, Sly WS. Molecular basis of human carbonic anhydrase II deficiency. Proc Natl Acad Sci U S A 1992; 89:1804.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/40\" class=\"nounderline abstract_t\">Pereira PC, Miranda DM, Oliveira EA, Silva AC. Molecular pathophysiology of renal tubular acidosis. Curr Genomics 2009; 10:51.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children/abstract/41\" class=\"nounderline abstract_t\">Batlle DC, Arruda JA, Kurtzman NA. Hyperkalemic distal renal tubular acidosis associated with obstructive uropathy. N Engl J Med 1981; 304:373.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 6121 Version 22.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H17\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">DISTAL (TYPE 1) RTA</a><ul><li><a href=\"#H3\" id=\"outline-link-H3\">Etiology</a><ul><li><a href=\"#H4\" id=\"outline-link-H4\">- Genetic causes</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">- Acquired causes</a></li></ul></li><li><a href=\"#H6\" id=\"outline-link-H6\">Clinical manifestations</a><ul><li><a href=\"#H7\" id=\"outline-link-H7\">- Recessive form</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">- Dominant form</a></li><li><a href=\"#H1355765948\" id=\"outline-link-H1355765948\">- Chronic kidney disease</a></li></ul></li></ul></li><li><a href=\"#H9\" id=\"outline-link-H9\">PROXIMAL (TYPE 2) RTA</a><ul><li><a href=\"#H10\" id=\"outline-link-H10\">Etiology</a><ul><li><a href=\"#H11\" id=\"outline-link-H11\">- Isolated proximal RTA</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">- Fanconi syndrome</a></li></ul></li><li><a href=\"#H13\" id=\"outline-link-H13\">Clinical features</a><ul><li><a href=\"#H14\" id=\"outline-link-H14\">- Clinical findings of Fanconi syndrome</a></li></ul></li></ul></li><li><a href=\"#H15\" id=\"outline-link-H15\">MIXED (TYPE 3) RTA</a></li><li><a href=\"#H16\" id=\"outline-link-H16\">ALDOSTERONE DEFICIENCY OR RESISTANCE (TYPE 4 RTA)</a></li><li><a href=\"#H17\" id=\"outline-link-H17\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"PEDS/6121|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=NEPH/58428\" class=\"graphic graphic_table\">- Characteristics of RTA</a></li><li><a href=\"image.htm?imageKey=NEPH/56437\" class=\"graphic graphic_table\">- Major causes of distal RTA</a></li><li><a href=\"image.htm?imageKey=PEDS/59008\" class=\"graphic graphic_table\">- Inherited causes RTA</a></li><li><a href=\"image.htm?imageKey=NEPH/68165\" class=\"graphic graphic_table\">- Major causes of proximal RTA</a></li><li><a href=\"image.htm?imageKey=NEPH/82440\" class=\"graphic graphic_table\">- Major causes of hypoaldosteronism</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=amphotericin-b-nephrotoxicity\" class=\"medical medical_review\">Amphotericin B nephrotoxicity</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=causes-and-clinical-manifestations-of-primary-adrenal-insufficiency-in-children\" class=\"medical medical_review\">Causes and clinical manifestations of primary adrenal insufficiency in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=causes-and-evaluation-of-hyperkalemia-in-adults\" class=\"medical medical_review\">Causes and evaluation of hyperkalemia in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cisplatin-nephrotoxicity\" class=\"medical medical_review\">Cisplatin nephrotoxicity</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-treatment-of-hypokalemia-in-adults\" class=\"medical medical_review\">Clinical manifestations and treatment of hypokalemia in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cystinosis\" class=\"medical medical_review\">Cystinosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=dent-disease-x-linked-recessive-nephrolithiasis\" class=\"medical medical_review\">Dent disease (X-linked recessive nephrolithiasis)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=disorders-of-tyrosine-metabolism\" class=\"medical medical_review\">Disorders of tyrosine metabolism</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-and-toxicity-of-cadmium\" class=\"medical medical_review\">Epidemiology and toxicity of cadmium</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=etiology-and-diagnosis-of-distal-type-1-and-proximal-type-2-renal-tubular-acidosis\" class=\"medical medical_review\">Etiology and diagnosis of distal (type 1) and proximal (type 2) renal tubular acidosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=etiology-diagnosis-and-treatment-of-hypoaldosteronism-type-4-rta\" class=\"medical medical_review\">Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=galactosemia-clinical-features-and-diagnosis\" class=\"medical medical_review\">Galactosemia: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hereditary-elliptocytosis-and-related-disorders\" class=\"medical medical_review\">Hereditary elliptocytosis and related disorders</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hereditary-spherocytosis\" class=\"medical medical_review\">Hereditary spherocytosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=ifosfamide-nephrotoxicity\" class=\"medical medical_review\">Ifosfamide nephrotoxicity</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=lead-nephropathy-and-lead-related-nephrotoxicity\" class=\"medical medical_review\">Lead nephropathy and lead-related nephrotoxicity</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=manifestations-of-and-risk-factors-for-aminoglycoside-nephrotoxicity\" class=\"medical medical_review\">Manifestations of and risk factors for aminoglycoside nephrotoxicity</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=mercury-toxicity\" class=\"medical medical_review\">Mercury toxicity</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-and-pathophysiology-of-renal-tubular-acidosis-and-the-effect-on-potassium-balance\" class=\"medical medical_review\">Overview and pathophysiology of renal tubular acidosis and the effect on potassium balance</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=renal-disease-in-sjogrens-syndrome\" class=\"medical medical_review\">Renal disease in Sj&ouml;gren's syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=renal-involvement-in-the-mitochondrial-cytopathies\" class=\"medical medical_review\">Renal involvement in the mitochondrial cytopathies</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=renal-manifestations-of-sickle-cell-disease\" class=\"medical medical_review\">Renal manifestations of sickle cell disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=renal-toxicity-of-lithium\" class=\"medical medical_review\">Renal toxicity of lithium</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-distal-type-1-and-proximal-type-2-renal-tubular-acidosis\" class=\"medical medical_review\">Treatment of distal (type 1) and proximal (type 2) renal tubular acidosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=wilson-disease-clinical-manifestations-diagnosis-and-natural-history\" class=\"medical medical_review\">Wilson disease: Clinical manifestations, diagnosis, and natural history</a></li></ul></div></div>","javascript":null}